PROMISS Diagnostics is a pioneering brand focused on fighting cancer through early detection. With a mission to provide a globally accessible, non-invasive, and precise diagnostic test for ovarian cancer, PROMISS Diagnostics aims to revolutionize the field of cancer diagnostics. Ovarian cancer is a highly lethal disease, causing more deaths than any other cancer of the female reproductive system in the United States.

Alarming statistics indicate that 1 in 79 women develops ovarian cancer in her lifetime, with 54% succumbing to the disease within five years. PROMISS Diagnostics is committed to changing this outcome by offering clinicians an innovative, non-invasive diagnostic test known as PROMISS. By detecting ovarian cancer early, PROMISS Diagnostics aims to improve patient outcomes, lower costs, and increase survival rates.

With their non-invasive patented technology, PROMISS Diagnostics brings certainty to both patients and clinicians in the battle against ovarian cancer. Moreover, by addressing the unmet needs of an untapped $2 billion market, PROMISS Diagnostics creates significant value for patients, payers, and healthcare providers. Join PROMISS Diagnostics in their mission to make a difference in the fight against cancer